Results 101 to 110 of about 12,554 (221)

Pertactin deficiency of Bordetella pertussis: Insights into epidemiology, and perspectives on surveillance and public health impact

Human Vaccines & Immunotherapeutics
Pertussis resurgence has been documented even in countries with high pediatric vaccine coverage. The proportion of Bordetella pertussis isolates not expressing pertactin (PRN) has increased in several countries where acellular pertussis (aP) vaccines are
Ulrich Heininger, Helena Martini, Jennifer Eeuwijk, Ivana Prokić, Adrienne P. Guignard, Elisa Turriani, Maurine Duchenne, Valérie Berlaimont   +7 more
doaj   +1 more source

Effect of immunization during pregnancy and pre-existing immunity on diphtheria-tetanus-acellular pertussis vaccine responses in infants. [PDF]

Emerg Microbes Infect, 2023
Knuutila A, Barkoff AM, Ivaska L, Tenhu E, Teräsjärvi J, van Gageldonk P, Buisman A, Mertsola J, He Q, PERISCOPE consortium.   +9 more
europepmc   +1 more source

The Update, February 13, 2012 [PDF]

, 2012
The Update is a bi-weekly web newsletter published by the Iowa Department of Public Health's Bureau of Family Health. It is posted the second and fourth week of every month, and provides useful job resource information for departmental health care ...

core  

Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy. [PDF]

Med Princ Pract, 2022
Alghounaim M, Alsaffar Z, Alfraij A, Bin-Hasan S, Hussain E.   +4 more
europepmc   +1 more source

Evaluating the Immunogenicity of the Pertussis Component of the DPT Vaccine in 12- month old Infants in Kerman City, 2015 [PDF]

, 2017
Background: Pertussis is a contagious infectious disease that is preventable by vaccine. This bacterial infection is caused by bordetella pertussis. Since pertussis vaccine coverage in Iran has not been studied recently and the type of vaccine used in ...
Dehaghani, Azam, Ebrahimpour, Maryam, Hosseninasab, Ali, Noormandi, Mohammad Mehdi   +3 more
core  

ADULT IMMUNIZATION WITH ACELLULAR PERTUSSIS VACCINE

The Pediatric Infectious Disease Journal, 1993
Objective. —To evaluate the safety and immunogenicity in adults of several different concentrations of an acellular pertussis vaccine. Design. —Double-blind, randomized, placebo-controlled trial. Setting. —Medical center immunization clinic. Participants. —One hundred eighteen healthy adult volunteers. Interventions.
openaire   +2 more sources

Poster Session 3

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Competition, coinfection and strain replacement in models of Bordetella Pertussis [PDF]

, 2015
Ayabina, D, Colijn, C, Nicoli, E, Trotter, C, Turner, K   +4 more
core   +1 more source

Poster Session 1

Pregnancy, Volume 2, Issue S1, January 2026.
wiley   +1 more source

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization. [PDF]

Front Immunol, 2023
Yount KS, Hall JM, Caution K, Shamseldin MM, Guo M, Marion K, Fullen AR, Huang Y, Maynard JA, Quataert SA, Deora R, Dubey P.   +11 more
europepmc   +1 more source